Company profile
Liminatus Pharma, Inc.
NASDAQ:LIMNBiotechnology: Biological Products (No Diagnostic Substances)
Clinical trials (0)
No records yet.
FDA applications (0)
No records yet.
Company profile
No records yet.
No records yet.